- Paper Report
- Open Access
A novel regulator of Th1 differentiation
- Andy Clark1
© Current Science Ltd 2000
- Published: 2 May 2000
T helper (Th) lymphocytes differentiate into distinct (Th1 and Th2) subsets, which can be distinguished on the basis of their profiles of cytokine secretion. Th1 and Th2 cells differ in function, and play different roles in T-cell-mediated pathophysiological processes. Th2 differentiation is reasonably well understood, and several transcription factors (TFs) have been implicated, including c-Maf, NFAT, GATA-3 and Stat6. In contrast Th1 differentiation is poorly understood. Whilst TFs such as Stat4, IRF-1 and ERM have been implicated, these are not thought to play primary roles in the specification of the Th1 differentiation pathway. To identify TFs involved in the Th1 differentiation pathway.
IL-2-promoter-binding factors were identified from a Th1 cDNA library by yeast one-hybrid screen. Positive clones were confirmed as Th1-specific by hybridisation with a radiolabelled Th1, but not an equivalent Th2 cDNA pool. Eight clones which were positive in both screens encoded a novel TF belonging to the 'T box' family, named T-bet. T-bet was expressed in Th1 cell lines and upregulated by stimulation with anti-CD3, or with PMA/ionomycin. T-bet was expressed early during differentiation of naive primary T cells in vitro to Th1 cells. The following observations implicated T-bet as a positive regulator of the Th1 marker gene IFN-?. Expression of T-bet coincided with the induction of IFN? in B and NK cells. Overexpressed T-bet activated an IFN-?-luciferase reporter construct, but negatively regulated an IL-2 luciferase reporter. Finally, T-bet activated expression of the endogenous IFN-? gene in transiently transfected EL4 cells and retrovirally transduced primary CD4+ cells. Further experiments suggested that T-bet can direct Th1 differentiation. Naive T cells were infected with T-bet retrovirus and maintained in Th2-inducing conditions for 7 days, after which the virally transduced cells significantly overexpressed IFN-? and underexpressed IL-4 when compared to controls. Strikingly, if retroviral infection was performed after 9, 21 or 28 days of Th2-inducing culture, T-bet was able to redirect "terminally differentiated" Th2 effector cells into the Th1 pathway, upregulating IFN-? and downregulating both IL-4 and IL-5. This downregulation of expression was also seen in a stable Th2 cell line. Negative regulation of IL-4 and IL-5 expression occurred in T cells lacking the IFN-? receptor, and thus was not secondary to IFN-? production.
A yeast one-hybrid screen of a Th1 cDNA library was performed, using part of the IL-2 promoter as 'bait'. This type of screen is used to isolate TFs on the basis of their interaction with the bait sequence, but provides no information about the functional properties of the factors isolated. A secondary screen employed pools of Th1- or Th2-specific radiolabelled cDNA. Expression of T-bet mRNA and protein was examined by northern and western blotting or by FACS analysis in a variety of haematopoetic cells and tissues. In some experiments naive T cells were driven to differentiate by culture with IL-12 and anti-IL-4 (Th1-inducing), or with IL-4, anti-IFN-? and anti-IL-12 (Th2-inducing). Effects of T-bet upon IL-2, IL-4 and IFN-? expression were assessed by co-expression with appropriate luciferase reporter constructs in EL4 cells. Remaining experiments used retroviral vectors designed to express either green fluorescent protein (GFP) alone, or both GFP and T-bet. Retrovirally transduced T cells were FACS-analysed for the expression of various cytokines.